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I am by nature a conservative person,
not much of a risk taker. Yet in life we
take risks all the time, even if we
don’t know it. We take a chance in
just crossing the street or driving to
work. How great is the risk that
something terrible will happen to us
as a result? Very small, as we all know,
or we’d never walk out of the door in
the morning. We may even buy a
lottery ticket (academic salaries being
what they are), even though we
realize that we are almost certainly
wasting our money. In the California
lottery, there’s a pretty small chance
of winning. To win a prize of any size
requires correctly selecting five of six
randomly chosen numbers between
1 and 51; the odds of doing this are
only about 1 in 67,000.
Recently I asked a good friend if
he would accept the bet that there
was a 1 in 30,000 chance that he
would die tomorrow. “Yes. Every day
of my life — those are really long
odds,” he replied. And, after all, how
often do we expect to win the lottery?
But I didn’t ask him this question
because I was interested in his
expectation of winning the lottery.
I asked because there is a genetic
disorder called Cornelia de Lange
Syndrome (CdLS), which occurs at
about this frequency (1 in 20,000 to
1 in 40,000) of live births. Children
with CdLS have a wide range of
physical and mental problems with
varying degrees of severity, including
growth retardation, limb
abnormalities, kidney problems,
defects of the digestive system,
speech disorders, hearing loss and
mental retardation. Many children
with CdLS live into adulthood, but
some live one or two years, and some
live only weeks or months.
How do I know all this about such
an obscure syndrome (raise your hand,
everyone who has heard of CdLS)? I
know because I had a daughter with
CdLS. She had several of the rarer
and more severe manifestations of the
syndrome (which were undetectable
prenatally despite all possible
technology), and lived only 31 days.
Current wisdom (such as it is)
says that CdLS results from a
dominant mutation in an unknown
autosomal gene. The mutation is
thought to arise most often in the
gametes of an unaffected individual,
as cases of vertical transmission are
extremely rare. Parents with one
affected child have an increased
chance — about 1 in 50 — of having
a second child with CdLS. This has
led to the hypothesis that there is
mosaicism in the germline of some
transmitting parents, with some
fraction of that individual’s gametes
harboring the mutation and the rest
being normal.
Events are making me reconsider
the value I place on certain types
of research
What all this means is that it would
be futile to try to screen parental
DNA from cells other than gametes
for the mutation; foetal cells would
need to be screened. But no screen
exists because finding the affected
gene is not going to be easy. There
are no large pedigrees of individuals
carrying the disorder that can be
followed and analyzed. Indeed, there
are very few affected individuals
from whom lymphocytes have been
immortalized and studied by
molecular geneticists (one of the labs
working on CdLS has managed, over
years of work, to generate only about
100 such cell lines). This has been an
intractable problem to study and I
know of only two laboratories that
are working on CdLS at the
molecular genetic level — one in the
UK and one in the US. 
In the past, I’ve had many
discussions with my husband, who is
also a biologist, about the relative
merits of basic and applied research.
Basic research — questions pursued
for their own merits — always
seemed to me more likely to yield
results untainted by the bias that
might arise from the desire for a
‘cure’ for a certain disease. After all,
did the war on cancer, that
much-vaunted US program of the
1960s and 1970s, give us a cure for
cancer? No, but because of it, we now
have a much better understanding of
the complexity and underlying causes
of cancer than we did when the war
started, even if the research hasn’t yet
led to an outright cure. 
When I told a colleague the story
of my daughter, she asked me if
having this happen made me want to
work on CdLS. You bet it does. And
it’s making me reconsider the value I
place on certain types of research.
Even though my lab may never be
involved directly in isolating the
gene that is mutated in CdLS, or in
developing a screen for the disease, I
will forever more be intellectually
involved with this research and
emotionally vested in its outcome.
I used to think that basic research
was somehow better than applied
research, but now I’ve changed my
mind. Now it seems entirely
worthwhile to focus one’s scientific
curiosity on problems whose
solutions will have a direct impact on
our lives and the lives of our children.
This is a self-centred opinion, I know.
Because what I want is for someone
to find a way to screen for CdLS.
I want biologists like myself to work
towards finding a way to prevent or
cure this and other birth defects. One
in 30,000 odds are no longer long
enough, at least for me.
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